NeraPharm + Cayman Chemical → Cayman Pharma

Cayman Pharma represents the joining of almost 60 years of experience with prostaglandin synthesis and biochemistry. NeraPharm brings to the new company a deep understanding of GMP manufacturing under US FDA and EMEA standards, and many years of experience supplying pharmaceutical grade active ingredients. The Czech company also provides Cayman with a tremendous boost in manufacturing capacity. Cayman, on the other hand, brings cutting edge knowledge both in the research field and in GMP methods for the most advanced prostaglandin compounds. Drug candidates for newer indications such as glaucoma, male and female sexual dysfunction, and pulmonary hypertension are all part of the Cayman portfolio.

Cayman Pharma will strive to make the best possible use of its joint EU and US GMP manufacturing operations to ensure that the prostaglandin API that the customer needs is properly certified and ready for release.